Skip to content

SwissADME

Molecular Modelling Group, University of Lausanne; SIB Swiss Institute of Bioinformatics

SwissADME is a free web tool operated by the University of Lausanne's Molecular Modelling Group and the SIB Swiss Institute of Bioinformatics that computes molecular parameters related to pharmacokinetics and dynamics properties, plus druglikeness indicators, from a list of SMILES.

Catalog updated ·

Overview

SwissADME is a web tool that calculates molecular parameters in relation with pharmacokinetics and dynamics properties, as stated in its own site description. It is operated by the Molecular Modelling Group of the University of Lausanne together with the SIB Swiss Institute of Bioinformatics, and users submit a list of SMILES to obtain per-molecule reports.

The site carries a Terms of Use page and a help/FAQ section, and belongs to the Swiss family of web tools (SwissDock, SwissTargetPrediction and others). A notice on the site records that the tool was modified (mid-May) to stop relying on a commercial chemistry toolkit whose academic support ended, while stating that the underlying technologies and parameters were not changed.

SwissADME is a hosted service: no source repository is published through this entry, no API is documented, and submitted molecules are subject to the site's terms of use. Computed values are model-based estimates for triage and teaching, not experimental measurements.

Key Features

  • Web interface accepting a list of SMILES for batch property calculation.
  • Physicochemical descriptors, pharmacokinetics- and dynamics-related parameters and druglikeness indicators presented in a per-molecule report.
  • Part of the Swiss web-tool family operated with the SIB Swiss Institute of Bioinformatics.

Use Cases

  • Profile small compound sets during early drug-discovery triage without installing software.
  • Compare computed ADME-related parameters across candidate molecules in teaching or discussion settings.

How to Use

Enter a list of SMILES on the site and read the generated per-molecule report. The tool is web-only; results depend on the models the operators run, and the site's terms of use apply to submitted data. See: https://www.swissadme.ch/

Sources and verification

This entry describes capabilities documented by the linked project sources. Catalog edits are not evidence of a successful run, compatibility test or scientific performance evaluation.

Repository source reviewed for this catalog version:

Read the editorial and verification policy

Related resources

ADMET-AI is an ADMET prediction platform built on Chemprop models trained on TDC ADMET datasets, offered via command line, Python API and a live web server, under the MIT license.

Open sourcePython

Molecular Property Prediction · Drug Discovery

CYPMode

Open Source

CYPMode is a research Python toolkit for time-dependent CYP3A4/CYP2D6 inhibition prediction and CYP3A4 ligand-complex modeling, developed around the OpenADMET blind challenge.

Open sourcePython

Molecular Property Prediction · Computational Chemistry · Drug Discovery

DrugAgent is a research multi-agent framework that combines LLM planning with domain-guided code generation to build and evaluate machine-learning workflows for drug discovery.

Molecular Property Prediction · Drug Discovery

ProTox 3.0

Platforms

ProTox 3.0 is the Charité web service for prediction of toxicities of small molecules, the successor to ProTox-II, offering web-based predictions and API usage documented in its FAQ.

Molecular Property Prediction · Drug Discovery

Therapeutics Data Commons provides therapeutic machine learning datasets, Python loaders, data splits, evaluation metrics and benchmarks for prediction and molecule-generation research.

Open sourcePython

Molecular Property Prediction · Drug Discovery

TorchDrug

Open Source

TorchDrug is a PyTorch-based toolkit for graph and molecular machine learning, with SMILES input, graph operations, property-prediction building blocks and multi-CPU/GPU execution.

Open sourcePython

Molecular Property Prediction · Drug Discovery

Related guides

Workflows

AI for Drug Discovery: Agents, MCP Servers and Platforms

Choose tools by workflow stage: target evidence, protein structures, known binding sites, molecular generation, property analysis and screening. Compare research agents, MCP integrations, hosted APIs and platforms, with a proposed end-to-end example and practical evaluation gates.